Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/09/1997 | WO1997000941A2 Novel system for multilayer growth of anchorage-dependent cells |
01/09/1997 | WO1997000888A1 Methods for reducing background binding in antibody preparations |
01/09/1997 | WO1997000698A1 Inhibition of hepatitis b replication |
01/09/1997 | WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor |
01/09/1997 | WO1996038560A3 Genetic control of flowering |
01/09/1997 | WO1996030540A3 Substrates for beta-lactamase and uses thereof |
01/09/1997 | CA2225600A1 Gibberellin-regulated myb polypepetides |
01/09/1997 | CA2225517A1 Haemopoietic growth factor antagonists and uses therefor |
01/09/1997 | CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
01/09/1997 | CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives |
01/09/1997 | CA2224799A1 A human edg-2 receptor homolog |
01/09/1997 | CA2224797A1 Immortalized epithelial tumor cell |
01/09/1997 | CA2224687A1 Methods for reducing background binding in antibody preparations |
01/09/1997 | CA2224477A1 Inhibition of hepatitis b replication |
01/09/1997 | CA2224247A1 Human homolog of the mouse rab18 gene |
01/09/1997 | CA2222270A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses |
01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
01/08/1997 | EP0752104A1 Differential expansion of fetal stem cells in the maternal circulation for use in prenatal genetic analysis |
01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
01/08/1997 | EP0751996A1 Luciferases |
01/08/1997 | EP0751995A1 Riboflavin synthesis in fungi |
01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
01/08/1997 | EP0751988A1 Highly efficient production and isolation of viral particles |
01/08/1997 | EP0751962A1 Methods and compositions for inhibiting cd14 mediated cell activation |
01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
01/08/1997 | EP0751955A1 Super proteins including interferons and interleukins |
01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
01/08/1997 | EP0751784A1 Thyroxin-binding proteins |
01/08/1997 | EP0751780A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
01/08/1997 | EP0706320B1 Method of controlling insects |
01/08/1997 | EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
01/08/1997 | EP0473724B1 A human cytokine, interleukin-9 |
01/08/1997 | EP0386166B1 PROTAMINE-REACTIVE IgM ANTIBODIES |
01/08/1997 | CN1139955A Human kunitz-type protease inhibitors |
01/08/1997 | CN1139871A Novel apopotsis-modulating proteins, DNA encoding the proteins and methods of use thereof |
01/08/1997 | CN1139703A Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
01/08/1997 | CN1033760C Protein with 8th activity factor, process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
01/07/1997 | US5591828 Genetic engineering |
01/07/1997 | US5591822 Hydrophobic attachment site for adhesion peptides |
01/07/1997 | US5591639 Plasmids and gene expression for dna sequences |
01/07/1997 | US5591629 Monoclonal antibodies which promote central nervous system remyelination |
01/07/1997 | US5591627 Circulation of cell medium over substrate with patterns of adhesive such as collagen |
01/07/1997 | US5591624 Retroviral packaging cell lines |
01/07/1997 | US5591623 Oligonucleotide modulation of cell adhesion |
01/07/1997 | US5591620 Methods of detecting and isolating a ripening form of a polypeptide having rhamnogalacturonase activity |
01/07/1997 | US5591616 Method for transforming monocotyledons |
01/07/1997 | US5591602 Nucleic acid encoding opioid receptor |
01/07/1997 | US5591598 Method for quantitating hydrazide groups |
01/07/1997 | US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor |
01/07/1997 | US5591579 Indicator cell line for detecting RNA viruses and method therefor |
01/07/1997 | US5591444 Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
01/07/1997 | US5591440 Hepatitis B Virus mutants, reagents and methods for detection |
01/07/1997 | CA1338829C Superior mammalian expression system |
01/07/1997 | CA1338827C Fruit-specific transcriptional factors |
01/03/1997 | WO1997000326A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
01/03/1997 | WO1997000319A2 Chimeric leptin fused to immunoglobulin domain and use |
01/03/1997 | WO1997000316A1 A process for producing trypsin (trypsinogen) |
01/03/1997 | WO1996037621A3 Multimeric proteins |
01/03/1997 | CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use |
01/02/1997 | EP0751217A2 Enhancing keratinocyte migration with clostridiopeptidase-A-collagenase |
01/02/1997 | EP0751147A1 Toxoplasma gondii antigen, its production and use |
01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
01/02/1997 | EP0750673A1 Transgenic production of oligosaccharides and glycoconjugates |
01/02/1997 | EP0750672A1 Dna sequences for matrix metalloproteases, their production and use |
01/02/1997 | EP0750671A1 Transgenic animals producing oligosaccharides and glycoconjugates |
01/02/1997 | EP0750664A1 Reproduction and utilization of functional human tissue |
01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
01/02/1997 | EP0750516A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides |
01/02/1997 | EP0750505A1 Immunotherapy of cancer with allogeneic lymphocytes |
01/02/1997 | EP0750503A1 Ribozyme therapy for restenosis |
01/02/1997 | EP0750458A1 Terminal complement inhibitor fusion genes and proteins |
01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
01/02/1997 | EP0691806A4 Method of causing somatic hybridization between two species of algae |
01/02/1997 | EP0556345B1 Retroviral vectors useful for gene therapy |
01/02/1997 | DE19526386C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
01/01/1997 | CN1139455A Thrombin mutants |
01/01/1997 | CN1139115A Anti-aV-integrin monoclonal antibody |
12/31/1996 | US5589624 Antifungal polypeptide and process for its production |
12/31/1996 | US5589621 Transformed plant cell |
12/31/1996 | US5589620 Isolated from plants; useful in transforming vectors, host organisms and plants; produce plants which exhibit an increased resistance towards pests |
12/31/1996 | US5589619 Increasing the amount of a gene encoding a polypeptide having hmg-coa reductase activity |
12/31/1996 | US5589614 Plant-derived glutathione-S-transferase isoform II promoter |
12/31/1996 | US5589610 Stamen-specific promoters from corn |
12/31/1996 | US5589582 Polynucleotides en coding porcine cytokines |
12/31/1996 | US5589573 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and DNA base sequences encoding those sequences |
12/31/1996 | US5589384 Formation of pentamer complex and binding to gangliosides and hinges of glycineproline and antigens or epitopes |
12/31/1996 | US5589379 Geminivirus-based gene expression system |
12/31/1996 | US5589377 Cells and genetic engineering |
12/31/1996 | US5589376 Cloning, transplanting |
12/31/1996 | US5589374 Diabetogene rad: a type II diabetes specific gene |
12/31/1996 | US5589369 Cells homozygous for disrupted target loci |
12/31/1996 | US5589345 Leukemia cells |
12/31/1996 | US5589338 Nucleic acids encoding a mutant form of human serum albumin involved in familial dysalbuminemic hyperthyroxinemia |
12/31/1996 | US5589334 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof |
12/31/1996 | US5589112 Constructing a high density cell culture system |
12/31/1996 | US5589047 Using dielectrophoresis for genetic engineering |